{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:57:44Z","timestamp":1774119464954,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12149-023-01844-x","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T12:02:04Z","timestamp":1682769724000},"page":"419-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Linking cardiac and extracardiac sarcoidosis and their clinical outcome: 18F-FDG PET\/CT analysis in patients with systemic cardiac sarcoidosis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5046-2444","authenticated-orcid":false,"given":"Koichiro","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinobu","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Eng J Med. 2007;357:2153\u201365.","journal-title":"N Eng J Med"},{"issue":"10 Pt 1","key":"1844_CR2","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1844_CR3","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6):2004079.","journal-title":"Eur Respir J"},{"issue":"155","key":"1844_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0146-2019","volume":"29","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020;29(155): 190146.","journal-title":"Eur Respir Rev"},{"key":"1844_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","volume":"153","author":"G Kirkil","year":"2018","unstructured":"Kirkil G, Lower EE, Baughman RP. Predictors of mortality in pulmonary sarcoidosis. Chest. 2018;153:105\u201313.","journal-title":"Chest"},{"issue":"2","key":"1844_CR6","doi-asserted-by":"publisher","first-page":"1701815","DOI":"10.1183\/13993003.01815-2017","volume":"51","author":"M Rossides","year":"2018","unstructured":"Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J. 2018;51(2):1701815.","journal-title":"Eur Respir J"},{"issue":"1","key":"1844_CR7","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1038\/s41598-019-40030-w","volume":"9","author":"KS Parikh","year":"2019","unstructured":"Parikh KS, Dahhan T, Nicholl L, Ruopp N, Pomann GM, Fortin T, et al. Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension. Sci Rep. 2019;9(1):4061.","journal-title":"Sci Rep"},{"key":"1844_CR8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","volume":"183","author":"JJ Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183:1524\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1844_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00005792-199903000-00001","volume":"78","author":"CJ Johns","year":"1999","unstructured":"Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the John Hopkins Hospital. Medicine (Baltimore). 1999;78(2):65\u2013111.","journal-title":"Medicine (Baltimore)"},{"key":"1844_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624\u201332.","journal-title":"Circulation"},{"key":"1844_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204\u201311.","journal-title":"Circulation"},{"key":"1844_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68:411\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"1844_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305\u201323.","journal-title":"Heart Rhythm"},{"key":"1844_CR14","first-page":"50","volume":"6","author":"E Hulten","year":"2016","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6:50\u201363.","journal-title":"Cardiovasc Diagn Ther"},{"key":"1844_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-022-03106-1","author":"K Kaneko","year":"2022","unstructured":"Kaneko K, Nagao M, Yamamoto A, Sakai A, Sakai S. Isolated and systemic cardiac sarcoidosis patients show different pre-treatment cardiac FDG uptake, but show similar prognosis. J Nucl Cardiol. 2022. https:\/\/doi.org\/10.1007\/s12350-022-03106-1.","journal-title":"J Nucl Cardiol"},{"key":"1844_CR16","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis\u2014digest version. Circ J. 2019;83:2329\u201388.","journal-title":"Circ J"},{"key":"1844_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12350-021-02567-0","volume":"28","author":"A Yamamoto","year":"2021","unstructured":"Yamamoto A, Nagao M, Watanabe E, Imamura Y, Suzuki A, Fukushima K, et al. Prognosis and recurrence in cardiac sarcoidosis: serial assessment of BMIPP SPECT and FDG-PET. J Nucl Cardiol. 2021;28:919\u201329.","journal-title":"J Nucl Cardiol"},{"key":"1844_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","volume":"28","author":"Y Ishida","year":"2014","unstructured":"Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med. 2014;28:393\u2013403.","journal-title":"Ann Nucl Med"},{"key":"1844_CR19","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","volume":"26","author":"S Ishimaru","year":"2005","unstructured":"Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26:1538\u201343.","journal-title":"Eur Heart J"},{"key":"1844_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58:1341\u201353.","journal-title":"J Nucl Med"},{"key":"1844_CR21","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","volume":"105","author":"RL Mostard","year":"2011","unstructured":"Mostard RL, V\u00f6\u00f6 S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, et al. Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis. Respir Med. 2011;105:1917\u201324.","journal-title":"Respir Med"},{"key":"1844_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","volume":"21","author":"A Ahmadian","year":"2014","unstructured":"Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, et al. Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925\u201339.","journal-title":"J Nucl Cardiol"},{"key":"1844_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","volume":"21","author":"MT Osborne","year":"2014","unstructured":"Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166\u201374.","journal-title":"J Nucl Cardiol"},{"key":"1844_CR24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"1844_CR25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155\u201367.","journal-title":"Lancet"},{"key":"1844_CR26","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","volume":"14","author":"M Subramanian","year":"2021","unstructured":"Subramanian M, Swapna N, Ali AZ, Saggu DK, Yalagudri S, Kishore J, et al. Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis. JACC Cardiovasc Imaging. 2021;14:2008\u201316.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1844_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1823710","author":"H Chen","year":"2018","unstructured":"Chen H, Jin R, Wang Y, Li L, Li K. The Utility of 18F-FDG PET\/CT for monitoring response and predicting prognosis after glucocorticoids therapy for sarcoidosis. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/1823710.","journal-title":"Biomed Res Int"},{"key":"1844_CR28","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1378\/chest.07-1178","volume":"132","author":"AS Teirstein","year":"2007","unstructured":"Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132:1949\u201353.","journal-title":"Chest"},{"key":"1844_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","volume":"24","author":"PI Lee","year":"2017","unstructured":"Lee PI, Cheng G, Alavi A. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol. 2017;24:19\u201328.","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"1844_CR30","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"1844_CR31","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","volume":"4","author":"K Banba","year":"2007","unstructured":"Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm. 2007;4:1292\u20139.","journal-title":"Heart Rhythm"},{"issue":"9","key":"1844_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005001","volume":"9","author":"E Hulten","year":"2016","unstructured":"Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, et al. Presence of Late Gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2016;9(9): e005001.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1844_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jjcc.2013.09.004","volume":"62","author":"KF Kusano","year":"2013","unstructured":"Kusano KF. Effect of corticosteroid on arrhythmic events in patients with cardiac sarcoidosis. J Cardiol. 2013;62:326\u20137.","journal-title":"J Cardiol"},{"key":"1844_CR34","first-page":"210","volume":"22","author":"CS Stees","year":"2011","unstructured":"Stees CS, Khoo MS, Lowery CM, Sauer WH. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2011;22:210\u20133.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1844_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","volume":"132","author":"NA Khan","year":"2017","unstructured":"Khan NA, Donatelli CV, Tonelli AR, Wiesen J, Ribeiro Neto ML, Sahoo D, et al. Toxicity risk from glucocorticoids in sarcoidosis patients. Respir Med. 2017;132:9\u201314.","journal-title":"Respir Med"},{"key":"1844_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.111.090662","volume":"53","author":"G Youssef","year":"2012","unstructured":"Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53:241\u20138.","journal-title":"J Nucl Med"},{"key":"1844_CR37","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jcmg.2019.11.021","volume":"13","author":"O Manabe","year":"2020","unstructured":"Manabe O, Koyanagawa K, Hirata K, Oyama-Manabe N, Ohira H, Aikawa T, et al. Prognostic value of 18F-FDG PET using texture analysis in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2020;13:1096\u20137.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1844_CR38","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153\u201365.","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/s12149-023-01850-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000}}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-023-01844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-023-01844-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-023-01844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:19:27Z","timestamp":1687367967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-023-01844-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s12149-023-01844-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12149-023-01850-z","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,29]]},"assertion":[{"value":"7 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12149-023-01850-z","URL":"https:\/\/doi.org\/10.1007\/s12149-023-01850-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no relationships that could be construed as a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}